A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.
More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.
“These plaques may also become dry and have a silver scaly appearance ... according to the NHS. A telltale sign of nail ...
A doctor has explained how to distinguish between a common skin condition that millions have and a more worrying contagious ...
Dr Grant said: “One of the most common symptoms of psoriasis is when the skin becomes inflamed with red patches of skin. This ...
Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers Squibb's much-touted rival deucravacitinib ...
Feb. 3, 2025 — Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the ...
J&J is hoping to show that the peptide drug can be a more patient-friendly alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23, such as J&J's own Tremfya ...
Guttate psoriasis may represent the initial stage of chronic plaque-type psoriasis. On resolution, post-inflammatory hypo or hyperpigmentation may result. There is no scarring. Patients should be ...
When interest rates are low, small-cap stocks begin to shine and outpace larger companies in value. These stocks are stocks with a market capitalization between $300 million and $3 billion.